SCHEMBL6997572

SCHEMBL6997572

CCCC[Sn](CCCC)(CCCC)c1cc2ccccc2n1COCC[Si](C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.39
TLR8 Q9NR97 3/20 0.33
ALDH1A1 P00352 4/20 0.32
KDM4E B2RXH2 2/20 0.32
HPGD P15428 2/20 0.32
GAA P10253 2/20 0.32
MTNR1A P48039 2/20 0.32
MTNR1B P49286 2/20 0.32
TP53 P04637 2/20 0.32
TSHR P16473 1/20 0.32
RXFP1 Q9HBX9 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
APAF1 O14727 1/20 0.31
RAD52 P43351 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL595036 0.83 NPC1 (0.33) NPC1ALDH1A1KDM4EHPGDGAA
SCHEMBL29776481 0.80 MAPT (0.31)
SCHEMBL27197086 0.80 MAPT (0.31)
SCHEMBL6867352 0.79 CNR2 (0.34) TLR8ALDH1A1KDM4EHPGDGAA
SCHEMBL8801877 0.77 TLR8 (0.47) TLR8ALDH1A1KDM4EHPGDGAA
SCHEMBL29287219 0.76 NPC1 (0.46) NPC1ALDH1A1KDM4ETP53TSHR
SCHEMBL8802333 0.75 TLR8 (0.49) TLR8ALDH1A1TP53SMN1; SMN2NPSR1
SCHEMBL19492427 0.75 NPC1 (0.45) NPC1ALDH1A1KDM4EHPGDMTNR1A
SCHEMBL19557281 0.74 NPC1 (0.42) NPC1ALDH1A1KDM4EHPGDGAA
SCHEMBL223273 0.73 DGAT1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109785-B1 INDOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF MALIGNANT AND OTHER DISEASES CAUSED BY PATHOLOGICAL CELL PROLIFERATION ZENTARIS AG (DE) 2003-01-02 EP disclosed
US-6407102-B1 TYROSINE KINASE AND PLATELET-DERIVED GROWTH FACTOR INHIBITORS; ANTICARCINOGENIC, ANTITUMOR, ANTIARTHRITIC AND ANTIPROLIFERATIVE AGENTS; RESTENOSIS, ARTERIOSCLEROSIS ZENTARIS AG (DE) 2002-06-18 US disclosed